MVF delivers 1H26 Underlying NPAT of $10.4m
Filed with ASX · · 3 pages · English
• The Company delivered 1H26 underlying NPAT(1) of $10.4 million, in line with guidance provided in November 2025. Strategic & Operational Performance • Maintained ART Sector leading clinical pregnancy rates following a further 0.6% increase in clinical pregnancy rate per embryo transferred (women aged <43 years) to 40.7% in January to September 2025. Up from 32.6% in CY18; • Performed 5,163 stimu
In the deck
Story so far
Earlier from Monash IVF
- 1H26 Appendix 4D and Financial Report
- NBIO withdrawn to acquire Monash IVF
- Monash IVF rejects NBIO proposal to acquire MVF
- 2025 AGM - Investor Presentation
- 2025 AGM - Chair Address
Later from Monash IVF
- 1H26 Results Presentation
- Revised NBIO to acquire MVF
- Monash IVF rejects revised non-binding indicative proposal
- Trading update
- FY2026 Results release postponed to 31 August 2026
Follow Monash IVF into a list and get an email when it puts out news.
Follow Monash IVF